CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Cipla USA, Inc. recalls Budesonide Inhalation Suspension

Read the official FDA notice

Published
30 Jul 2025
Units affected
13,680 ampoules
Agency
FDA
Country
United States

The hazard

Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton)

Brand / company
Cipla USA, Inc.
Codes / lots
Batch # 4IA0505, Exp 09/31/2026
Distribution
Distributed Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 30 Jul 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.